TVRD CIK: 1346830

Tvardi Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−60.1
FY22:
−78.7
FY23:
−92.1
FY24:
−18.3
FY25:
−23.5
Change from FY21 to FY25
millions USD
FY21:
−4.75
FY22:
129
FY23:
43.5
FY24:
48.7
FY25:
−10.1
Change from FY21 to FY25
millions USD
FY21:
46.6
FY22:
0.31
FY23:
38.2
FY24:
27.0
FY25:
22.7
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
8.70
FY25:
−10.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−60.1
FY22:
−78.8
FY23:
−94.5
FY24:
−19.4
FY25:
−23.5

All amounts in millions USD Data sources:SEC EDGARTwelve Data